Copyright © 2001 by the European Society of Cardiology.
Trends in cardiogenic shock: report from the SHOCK Study
a St. Luke's-Roosevelt Hospital Center, Columbia University, New York, New York, U.S.A.
b New England Research Institutes, Watertown, Massachusetts, U.S.A.
c St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada
d University of Alberta Hospital, Edmonton, Alberta, Canada
e Mt. Sinai Medical Center, New York, New York, U.S.A.
revised June 5, 2000; accepted June 7, 2000
Abstract
Aims We analysed time trends in patient characteristics, management, and outcomes of cardiogenic shock complicating acute myocardial infarction in the international, prospective SHOCK Trial Registry and pre-study Registry.
Background Despite therapeutic advances in its management, the incidence and high mortality of this complication has remained unchanged for decades. However, in recent years mortality was reported to decrease in one community concomitant with increasing use of revascularization.
Methods Thirty-six centres registered 1380 patients with suspected cardiogenic shock complicating acute myocardial infarction from January 1992 to August 1997. Patient and myocardial infarction characteristics, haemodynamics, medications, procedure use, and vital status at discharge were recorded.
Results In all, 79% of patients had shock due to predominant pump failure (non-mechanical aetiology). The aetiology, patient profile, and clinical characteristics of cardiogenic shock did not differ over time, except for increases in the incidence of prior bypass surgery (P=0·054) and transfers to tertiary centres (P=0·008). In all, 44% underwent revascularization (n=485), with angioplasty performed more often than bypass surgery (69% vs 31%). The revascularization rate increased over time (P=0·006) with a significant decrease in the time to revascularization (P=0·033). The use of Swan–Ganz catheterization decreased over time (P=0·018), as did the mean length of hospitalization (P=0·034). Overall in-hospital mortality was high (63%) but decreased over time in all patients (P=0·004) and those with pump failure (P=0·018). Mortality was lower for patients who underwent revascularization compared to those who were not revascularized (41% vs 79%,P <0·001).
Conclusions Cardiogenic shock complicating acute myocardial infarction is associated with a high mortality rate, but mortality decreased significantly from 1992 to 1997. This partly reflects the greater use of revascularization, which was associated with better outcomes. The reported international trend towards shorter admissions for myocardial infarction was also observed in this cohort.
Key Words: Myocardial infarction, cardiogenic shock, prognosis, and mortality
f1 Correspondence: Judith S. Hochman, MD, St. Luke's-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025, U.S.A.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. S. Hochman and A. H. Skolnick Contemporary Management of Cardiogenic Shock: Age Is Opportunity J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 153 - 155. [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Mehta, J. D. Grab, S. M. O'Brien, D. D. Glower, C. K. Haan, J. S. Gammie, E. D. Peterson, and on Behalf of the Society of Thoracic Surgeons Nati Clinical Characteristics and In-Hospital Outcomes of Patients With Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Insights From the Society of Thoracic Surgeons National Cardiac Database Circulation, February 19, 2008; 117(7): 876 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Garcia-Gonzalez, A. Dominguez-Rodriguez, J. J. Ferrer-Hita, P. Abreu-Gonzalez, and M. B. Munoz Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics Eur J Heart Fail, November 1, 2006; 8(7): 723 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Migliorini and D. Antoniucci Patient selection bias in primary percutaneous coronary intervention trials: a critical issue Eur. Heart J. Suppl., October 1, 2005; 7(suppl_I): I21 - I26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. El-Banayosy, D. Cobaugh, A. Zittermann, L. Kitzner, L. Arusoglu, M. Morshuis, H. Milting, G. Tenderich, and R. Koerfer A Multidisciplinary Network To Save the Lives of Severe, Persistent Cardiogenic Shock Patients Ann. Thorac. Surg., August 1, 2005; 80(2): 543 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Dzavik, L.A. Sleeper, T.P. Cocke, M. Moscucci, J. Saucedo, S. Hosat, X. Jiang, J. Slater, T. LeJemtel, J.S. Hochman, et al. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry Eur. Heart J., May 1, 2003; 24(9): 828 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Menon and J. S Hochman MANAGEMENT OF CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION Heart, December 1, 2002; 88(5): 531 - 537. [Full Text] [PDF]
|
|
|
|
|
|
M.S. Marber and S.R. Redwood The management of cardiogenic shock: can anything be learnt from registries? Eur. Heart J., March 2, 2001; 22(6): 444 - 445. [PDF]
|
|